Balanced glucose helps stabilize energy and curb cravings
This piece walks through what the Ro weight-loss program actually involves: the intake, the provider model, the medication choices, the cost drivers, and the one upstream factor the program does not measure
Meanwhile, obesity drug biotech Metsera, founded in April 2022, is developing new GLP-1 injectables that can be taken once a month instead of once a week and seem to have fewer side effects than other options
And not just a little bit more weight, they lost another 10% of their body weight
The decision to get B12 injections should be guided by lab results, honest risk-benefit discussions with a qualified provider, and clarity about whether you are treating a diagnosed deficiency or pursuing an elective wellness service